Heavy metals and human health: Mechanistic insight into toxicity and counter defense system of antioxidants

International Journal of Molecular Sciences

Volumn 16, Issue 12, 2015, Pages 29592-29630

  Jan, Arif Tasleem ^a   Azam, Mudsser ^b   Siddiqui, Kehkashan ^b   Ali, Arif ^b   Choi, Inho ^a   Haq, Qazi Mohd Rizwanul ^b  

^a Yeungnam University   (South Korea)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Biomolecules; Dietary antioxidants; Free radicals; Heavy metals

Indexed keywords

ACETYLCYSTEINE; ARSENIC; ASCORBIC ACID; CAROTENOID; COPPER; GLUTATHIONE; HEAVY METAL; IRON; LEAD; MELATONIN; MERCURY; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TAURINE; THIOCTIC ACID; ZINC; ANTIOXIDANT; POLLUTANT;

ANTIOXIDANT ACTIVITY; CYTOTOXICITY; DIET; EXPOSURE; HEAVY METAL POISONING; HUMAN; LIPID PEROXIDATION; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; NUCLEIC ACID ANALYSIS; REVIEW; ANIMAL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; POLLUTANT; PROTECTION; TOXICITY;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; ENVIRONMENTAL POLLUTANTS; GLUTATHIONE; HUMANS; METALS, HEAVY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTECTIVE FACTORS;

EID: 84949870977     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161226183     Document Type: Review

References (298)

1. Bennett, L.E.; Burkhead, J.L.; Hale, K.L.; Tery, N.; Pilon, M.; Pilon-Smits, E.A.H. Analysis of transgenic Indian mustard plants for Phytoremediation of metal contaminated mine tailings. J. Environ. Qual. 2003, 32, 432–440. [CrossRef]
2. Ikhuoria, E.U.; Okieimen, F.E. Scavenging cadmium, copper, lead, nickel and zinc ions from aqueous solution by modified cellulosic sorbent. Int. J. Environ. Stud. 2000, 57, 401–409. [CrossRef]
3. Sahu, R.K.; Arora, N.K. Bioassay as a tool for assessing susceptibility and resistant plant species for field contaminated with industrial effluents. World J. Microbiol. Biotechnol. 2008, 24, 143–148. [CrossRef]
4. Jaishankar, M.; Mathew, B.B.; Shah, M.S.; Murthy, K.T.P.; Gowda, S.K.R. Biosorption of few heavy metal ions using agricultural wastes. J. Environ. Pollut. Hum. Health 2014, 2, 1–6.
5. Nagajyoti, P.C.; Lee, K.D.; Sreekanth, T.V.M. Heavy metals, occurrence and toxicity for plants: A review. Environ. Chem. Lett. 2010, 8, 199–216. [CrossRef]
6. Meharg, A.A. Arsenic in rice–understanding a new disaster for south-east Asia. Trends Plant. Sci. 2004, 9, 415–417. [CrossRef][PubMed]
7. Cheng, S.P. Heavy metal pollution in China: Origion, pattern and control. Environ. Sci. Pollut. Res. Int. 2003, 10, 192–198. [CrossRef][PubMed]
8. D’Souza, C.; Peretiatko, R. The nexus between industrialization and environment: A case study of Indian enterprises. Environ. Manag. Health 2002, 13, 80–97. [CrossRef]
9. Flora, S.J.S.; Mittal, M.; Mehta, A. Heavy metal induced oxidative stress and its reversal by chelation therapy. Ind. J. Med. Res. 2008, 128, 501–523.
10. Jan, A.T.; Ali, A.; Haq, Q.M.R. Glutathione as an antioxidant in inorganic mercury induced nephrotoxicity. J. Postgrad. Med. 2011, 57, 72–77. [PubMed]
11. Chen, C.W.; Chen, C.F.; Dong, C.D. Distribution and Accumulation of Mercury in Sediments of Kaohsiung River Mouth, Taiwan. APCBEE Procedia 2012, 1, 153–158. [CrossRef]
12. Jan, A.T.; Murtaza, I.; Ali, A.; Haq, Q.M.R. Mercury pollution: An emerging problem and potential bacterial remediation strategies. World J. Microbiol. Biotechnol. 2009, 25, 1529–1537. [CrossRef]
13. Chang, L.W. Neurotoxic effects of mercury: A review. Environ. Res. 1977, 14, 329–373. [CrossRef]
14. Asano, S.; Eto, K.; Kurisaki, E.; Gunji, H.; Hiraiwa, K.; Sato, M.; Sato, H.; Hasuike, M.; Hagiwara, N.; Wakasa, H. Acute inorganic mercury vapour inhalation poisoning. Pathol. Int. 2000, 50, 169–174. [CrossRef][PubMed]
15. Bates, N. Metallic and inorganic mercury poisoning. Emerg. Nurse 2003, 11, 25–31. [CrossRef][PubMed]
16. Clarkson, T.W. Mercury: Major issues in environmental health. Environ. Health Perspect. 1993, 100, 31–38. [CrossRef][PubMed]
17. Farina, M.; Aschner, M.; Rocha, J.B.T. Oxidative stress in methylmercury induced neurotoxicity. Toxicol. Appl. Pharm. 2011, 256, 405–417. [CrossRef][PubMed]
18. Geier, D.A.; King, P.G.; Hooker, B.S.; Dorea, J.G.; Kern, J.K.; Sykes, L.K.; Geier, M.R. Thimerosal: Clinical, epidemiologic and biochemical studies. Clin. Chim. Acta 2015, 444, 212–220. [CrossRef][PubMed]
19. Hintelmann, H. Organomercurials: Their formation and pathways in the environment. Met Ions Life Sci. 2010, 7, 365–401. [PubMed]
20. Patrick, L. Mercury toxicity and antioxidants: Part 1: role of glutathione and _-lipoic acid in the treatment of mercury toxicity. Altern. Med. Rev. 2002, 7, 456–471. [PubMed]
21. Carneiro, M.F.H.; Oliveira Souza, J.M.; Grotto, D.; Batista, B.L.; de Oliveira Souza, V.C.; Barbosa, F., Jr. A systemic study of the deposition and metabolism of mercury species in mce after exposure to low levels of Thimerosal (ethylmercury). Environ. Res. 2014, 134, 218–227. [CrossRef][PubMed]
22. ASTDR. Toxicological profile for mercury. Available online: http://www.atsdr.cdc.gov/toxprofiles/ tp.asp?id=115&tid=24 (accessed on 22 September 2015).
23. WHO. Guidelines for drinking-water quality. Sixty-first meeting, Rome, 10–19 June 2003. Joint FAO/WHO Expert Committee on Food Additives, 2004. Available online: http://ftp.fao.org/es/esn/jecfa/ jecfa61sc.pdf (accessed on 2 October 2015).
24. Zalups, R.K.; Lash, L.H. Advances in understanding the renal transport and toxicity of mercury. J. Toxicol. Environ. Health 1994, 42, 1–44. [CrossRef][PubMed]
25. ATSDR. Toxicological profile for arsenic. 2007. Available online: http://www.atsdr.cdc.gov/toxprofiles/ tp.asp?id=22&tid=3 (accessed on 22 September 2015).
26. EPA. An overview of Airborne Metal Regulations, Exposure Limits, Health Effects and Contemporary Research (Appendix C). 2010. Available online: http://www3.epa.gov/ttnemc01/prelim/ otm31appC.pdf(accessed on 2 October 2015).
27. ATSDR. Toxicological profile for lead. 2007. Available online: http://www.atsdr.cdc.gov/toxprofiles/ tp.asp?id=96&tid=22 (accessed on 22 September 2015).
28. Langworth, S.; Elinder, C.G.; Sundquist, K.G.; Vesterberg, O. Renal and immunological effects of occupational exposure to inorganic mercury. Br. J. Ind. Med. 1992, 49, 394–401. [CrossRef][PubMed]
29. Cardenas, A.; Roels, H.; Bernard, A.M.; Barbon, R.; Lauwerys, R.R.; Rosello, J.; Hotter, G.; Mutti, A.; Franchini, I.; Fels, L.M. et al. Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapor. Br. J. Ind. Med. 1993, 50, 17–27. [PubMed]
30. Franko, A.; Budihna, M.V.; Dodic-Fikfak, M. Long-term effects of elemental mercury on renal function in miners of the Idrija Mercury mine. Ann. Occup. Hyg. 2005, 49, 521–527. [CrossRef][PubMed]
31. Al-Saleh, I.; Al-Sedairi, A.; Elkhatib, R. Effect of mercury (Hg) dental amalgam fillings on renal and oxidative stress biomarkers in children. Sci. Total Environ. 2012, 431, 188–196. [CrossRef][PubMed]
32. Li, Y.; Zhang, B.; Yang, L.; Li, H. Blood mercury concentration among residents of a historic mercury mine and possible effects on renal function: a cross sectional study in south western China. Environ. Monit. Assess. 2013, 185, 3049–3055. [CrossRef][PubMed]
33. Zalups, R.K. Molecular intereactions with mercury in the kidney. Pharmacol. Rev. 2000, 52, 113–143. [PubMed]
34. Zalups, R.K.; Barfuss, D.W. Accumulation of inorganic mercury along the renal proximal tubule of the rabbit. Toxicol. Appl. Pharmacol. 1990, 106, 245–253. [CrossRef]
35. Zalups, R.K. Method for studying the in vivo accumulation of inorganic mercury in segments of the nephron in the kidneys of rats treated with mercuric chloride. J. Pharmacol. Methods 1991, 26, 89–104. [CrossRef]
36. Tanaka-Kagawa, T.; Naganuma, A.; Imura, N. Tubular secretion and reabsorption of mercury compounds in mouse kidney. J. Pharmacol. Exp. Ther. 1993, 264, 776–782. [PubMed]
37. DeCeaurriz, J.; Payan, J.P.; Morel, G.; Brondeau, M.T. Role of extracellular glutathione and -glutamyltranspeptidase in the disposition and kidney toxicity of inorganic mercury in rats. J. Appl. Toxicol. 1994, 14, 201–206. [CrossRef]
38. Zalups, R.K. Organic anion transport and action of g-glutamyltranspeptidase in kidney linked mechanistically to renal tubular uptake of inorganic mercury. Toxicol. Appl. Pharmacol. 1995, 132, 289–298. [CrossRef][PubMed]
39. Zalups, R.K.; Barfuss, D.W. Participation of mercuric conjugates of cysteine, homocysteine, and N-acetylcysteine in mechanisms involved in the renal tubular uptake of inorganic mercury. J. Am. Soc. Nephrol. 1998, 9, 551–561. [PubMed]
40. Cannon, V.T.; Zalups, R.K.; Barfuss, D.W. Molecular homology and the luminal transport of Hg2+ in the renal proximal tubule. J. Am. Soc. Nephrol. 2000, 11, 394–402. [PubMed]
41. Zalups, R.K. Basolateral uptake of inorganic mercury in the kidney. Toxicol. Appl. Pharmacol. 1998, 150, 1–8. [CrossRef][PubMed]
42. Bridges, C.C.; Zalups, R.K. Molecular and ionic mimicry and the transport of toxic metals. Toxicol. Appl. Pharmacol. 2005, 204, 274–308. [CrossRef][PubMed]
43. Torres, A.M.; Dnyanmote, A.V.; Bush, K.T.; Wu, W.; Nigam, S.K. Deletion of multispecific organic anion transporter (Oat1/Slc22a6) protects from mercury-induced kidney injury. J. Biol. Chem. 2011, 286, 26391–26395. [CrossRef][PubMed]
44. Bridges, C.C.; Zalups, R.K. Transport of inorganic mercury and methylmercury in target tissues and organs. J. Toxicol. Environ. Health Crit. Rev. 2010, 13, 385–410. [CrossRef][PubMed]
45. Bridges, C.C.; Joshee, L.; Zalups, R.K. Multidrug resistance proteins and the renal elimination of inorganic mercury mediated by 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid. J. Pharmacol. Exp. Ther. 2008, 324, 383–390. [CrossRef][PubMed]
46. Compeau, G.C.; Bartha, R. Sulfate-reducing bacteria: Principal methylators of mercury in anoxic estuarine sediment. Appl. Environ. Microbiol. 1985, 50, 498–502. [PubMed]
47. Clarkson, T.W.; Magos, L.; Myers, G.J. Toxicology of mercury—current exposures and clinical manifestations. N. Engl. J. Med. 2003, 349, 1731–1737. [CrossRef][PubMed]
48. National Research Council. Toxicological Effect of Methylmercury; National Academies Press: Washington, DC, USA, 2000.
49. European Food Safety Authority (EFSA). Panel on contaminants in food chain: Scientific opinion on the risk for public health related to presence of mercury and methylmercury in food. EFSA J. 2012, 10, 2985.
50. Zareba, G.; Cernichiari, E.; Hojo, R.; Nitt, S.M.; Weiss, B.; Mumtaz, M.M.; Jones, D.E.; Clarkson, T.W. Thimerosal distribution and metabolism in neonatal mice: Comparison with methyl mercury. J. Appl. Toxicol. 2007, 27, 511–518. [CrossRef][PubMed]
51. Yin, Z.; Jiang, H.; Syversen, T.; Rocha, J.B.; Farina, M.; Aschner, M. The methylmercury-L-cysteine conjugate is a substrate for the L-type large neutral amino acid transporter. J. Neurochem. 2008, 107, 1083–1090. [CrossRef][PubMed]
52. Johansson, C.; Castoldi, A.F.; Onishchenko, N.; Manzo, L.; Vahter, M.; Ceccatelli, S. Neurobehavioural and molecular changes induced by methylmercury exposure during development. Neurotox. Res. 2007, 11, 241–260. [CrossRef][PubMed]
53. Pivovarova, N.B.; Andrews, S.B. Calcium-dependent mitochondrial function and dysfunction in neurons. FEBS J. 2010, 277, 3622–3636. [CrossRef][PubMed]
54. Denny, M.F.; Atchison, W.D. Mercurial-induced alterations in neuronal divalent cation homeostasis. Neurotoxicology 1996, 17, 47–61. [PubMed]
55. Gasso, S.; Cristofol, R.M.; Selema, G.; Rosa, R.; Rodriguez-Farre, E.; Sanfeliu, C. Antioxidant compounds and Ca2+ pathway blockers differentially protect against methylmercury and mercuric chloride neurotoxicity. J. Neurosci. Res. 2001, 66, 135–145. [CrossRef][PubMed]
56. Limke, T.L.; Heidemann, S.R.; Atchison, W.D. Disruption of intraneuronal divalent cation regulation by methylmercury: Are specific targets involved in altered neuronal development and cytotoxicity in methylmercury poisoning? Neurotoxicology 2004, 25, 741–760. [CrossRef][PubMed]
57. Wagner, C.; Sudati, J.H.; Nogueira, C.W.; Rocha, J.B. In vivo and in vitro inhibition of mice thioredoxin reductase by methylmercury. Biometals 2010, 23, 1171–1177. [CrossRef][PubMed]
58. Branco, V.; Canario, J.; Holmgren, A.; Carvalho, C. Inhibition of the thioredoxin system in the brain and liver of zebra sea breams exposed to waterborne methylmercury. Toxicol. Appl. Pharmacol. 2011, 251, 95–103. [CrossRef][PubMed]
59. Farina, M.; Campos, F.; Vendrell, I.; Berenguer, J.; Barzi, M.; Pons, S.; Sunol, C. Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells. Toxicol. Sci. 2009, 112, 416–426. [CrossRef][PubMed]
60. Wagner, C.; Vargas, A.P.; Roos, D.H.; Morel, A.F.; Farina, M.; Nogueira, C.W.; Aschner, M.; Rocha, J.B. Comparative study of quercetin and its two glycoside derivatives quercitrin and rutin against methylmercury (MeHg)-induced ROS production in rat brain slices. Arch. Toxicol. 2010, 84, 89–97. [CrossRef][PubMed]
61. Carvalho, C.M.; Lu, J.; Zhang, X.; Arner, E.S.; Holmgren, A. Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: Implications for treatment of mercury poisoning. FASEB J. 2010, 25, 370–381. [CrossRef][PubMed]
62. Kaur, P.; Aschner, M.; Syversen, T. Glutathione modulation influences methylmercury induced neurotoxicity in primary cell cultures of neurons and astrocytes. Neurotoxicology 2006, 27, 492–500. [CrossRef][PubMed]
63. Franco, J.L.; Braga, H.C.; Stringari, J.; Missau, F.C.; Posser, T.; Mendes, B.G.; Leal, R.B.; Santos, A.R.; Dafre, A.L.; Pizzolatti, M.G. et al. Mercurial-induced hydrogen peroxide generation in mouse brain mitochondria: protective effects of quercetin. Chem. Res. Toxicol. 2007, 20, 1919–1926. [CrossRef][PubMed]
64. Amonpatumrat, S.; Sakurai, H.; Wiriyasermkul, P.; Khunweeraphong, N.; Nagamori, S.; Tanaka, H.; Piyachaturawat, P.; Kanai, Y. L-glutamate enhances methylmercury toxicity by synergistically increasing oxidative stress. J. Pharmacol. Sci. 2008, 108, 280–289. [CrossRef][PubMed]
65. Roos, D.H.; Puntel, R.L.; Farina, M.; Aschner, M.; Bohrer, D.; Rocha, J.B.; De Vargas Barbosa, N.B. Modulation of methylmercury uptake by methionine: prevention of mitochondrial dysfunction in rat liver slices by a mimicry mechanism. Toxicol. Appl. Pharmacol. 2011, 252, 28–35. [CrossRef][PubMed]
66. Usuki, F.; Yamashita, A.; Fujimura, M. Post-transcriptional defects of antioxidant selenoenzymes cause oxidative stress under methylmercury exposure. J. Biol. Chem. 2009, 286, 6641–6649. [CrossRef][PubMed]
67. Allen, J.W.; Mutkus, L.A.; Aschner, M. Methylmercury-mediated inhibition of 3 HD-aspartate transport in cultured astrocytes is reversed by the antioxidant catalase. Brain Res. 2001, 902, 92–100. [CrossRef]
68. Mori, N.; Yasutake, A.; Hirayama, K. Comparative study of activities in reactive oxygen species production/defense system in mitochondria of rat brain and liver, and their susceptibility to methylmercury toxicity. Arch. Toxicol. 2007, 81, 769–776. [CrossRef][PubMed]
69. Dorea, J.G. Making sense of epidemiological studies of young children exposed to thimerosal in vaccines. Clin. Chim. Acta 2010, 411, 1580–1586. [CrossRef][PubMed]
70. ASTDR. Priority list of hazardous substances. 2013. Available online: http://www.atsdr.cdc.gov/spl/ (accessed on 22 September 2015).
71. Hughes, M.F.; Beck, B.D.; Chen, Y.; Lewis, A.S.; Thomas, D.J. Arsenic exposure and toxicology: A historical perspective. Toxicol. Sci. 2011, 123, 305–332. [CrossRef][PubMed]
72. Mandal, B.K.; Suzuki, K.T. Arsenic round the world: A Review. Talanta 2002, 58, 201–235. [CrossRef]
73. Singh, N.; Kumar, D.; Sahu, A. Arsenic in the environment: Effects on human health and possible prevention. J. Environ. Biol. 2007, 28, 359–365. [PubMed]
74. Kaur, S.; Kamli, M.R.; Ali, A. Role of arsenic and its resistance in nature. Can. J. Microbiol. 2011, 57, 769–774. [CrossRef][PubMed]
75. Sohn, E. The toxic side of rice. Nature 2014, 514, 62–63. [CrossRef]
76. Kulshrestha, A.; Jarouliya, U.; Prasad, G.B.K.S.; Flora, S.J.S.; Bisen, P.S. Arsenic-induced abnormalities in glucose metabolism: Biochemical basis and potential therapeutic and nutritional interventions. World J. Transl. Med. 2014, 3, 96–111. [CrossRef]
77. Naujokas, M.; Anderson, B.; Ahsan, H.; Aposhian, H.V.; Graziano, J.H.; Thompson, C.; Suk, W.A. The broad scope of health effects from chronic arsenic exposure: Update on a worldwide public health problem. Environ. Health Perspect. 2013, 121, 295–302. [CrossRef][PubMed]
78. Ramos-Chavaz, L.A.; Rendon-Lopez, C.R.R.; Zepeda, A.; Silva-Adaya, D.; Razo, L.M.D.; Gonsebatt, M.E. Neurological effects of inorganic arsenic exposure: Altered cysteine/glutamate transport, NMDA expression and spatial memory impairment. Front. Cell. Neurosci. 2015, 9, 1–12.
79. Villa-Bellosta, R.; Sorribas, V. Role of rat sodium/phosphate cotransporters in the cell membrane transport of arsenate. Toxicol. Appl. Pharmacol. 2008, 232, 125–134. [CrossRef][PubMed]
80. Calatayud, M.; Barrios, J.A.; Velez, D.; Devesa, V. In vitro study of transporters involved in intestinal absorption of inorganic arsenic. Chem. Res. Toxicol. 2012, 25, 446–453. [CrossRef][PubMed]
81. Maciaszczyk-Dziubinska, E.; Wawrzycka, D.; Wysocki, R. Arsenic and antimony transporters in eukaryotes. Int. J. Mol. Sci. 2012, 13, 3527–3548. [CrossRef][PubMed]
82. Flora, S.J.S. Arsenic-induced oxidative stress and its reversibility. Free Radic. Biol. Med. 2011, 51, 257–281. [CrossRef][PubMed]
83. Styblo, M.; del Razo, L.M.; Vega, L.; Germolec, D.R.; LeCluyse, E.L.; Hamilton, G.A.; Reed, W.; Wang, C.; Cullen, W.R.; Thomas, D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 2000, 74, 289–299. [CrossRef][PubMed]
84. Sharma, B.; Singh, S.; Siddiqi, N.J. Biomedical implications of heavy metal induced imbalances in redox systems. BioMed Res. Int. 2014, 2014, 640754. [CrossRef][PubMed]
85. Smith, A.H.; Lingas, E.O.; Rahman, M. Contamination of drinking-water by arsenic in Bangladesh: A public health emergency. Bull. World Health Organ. 2000, 78, 1093–1103. [PubMed]
86. Shi, H.; Shi, X.; Liu, K.J. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol. Cell. Biochem. 2004, 255, 67–78. [CrossRef][PubMed]
87. Yoshida, T.; Yamauchi, H.; Fan Sun, G. Chronic health effects in people exposed to arsenic via the drinking water: Dose-response relationships in review. Toxicol. Appl. Pharmacol. 2004, 198, 243–252. [CrossRef][PubMed]
88. Hopenhayn, C. Arsenic in drinking water: impact on human health. Elements 2006, 2, 103–107. [CrossRef]
89. Gordon, J.J.; Quastel, G.H. Effect of organic arsenicals on enzyme system. Biochem. J. 1948, 42, 337–350. [CrossRef][PubMed]
90. Mazumder, G. Chronic arsenic toxicity and human health. Indian J. Med. Res. 2008, 128, 436–447.
91. Lin, S.; Shi, Q.; Nix, F.B.; Styblo, M.; Beck, M.A.; Herbin-Davis, K.M.; Hall, L.L.; Simeonsson, J.B.; Thomas, D.J. A novel S-adenosyl-L-methionine: ArsenicIII methyltransferase from rat liver cytosol. J. Biol. Chem. 2002, 277, 10795–10803. [CrossRef][PubMed]
92. Waters, S.B.; Devesa, V.; DelRazo, L.M.; Styblo, M.; Thomas, D.J. Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase. Chem. Res. Toxicol. 2004, 17, 404–409. [CrossRef][PubMed]
93. Thomas, D.J. Unraveling arsenic-glutathione connections. Toxicol. Sci. 2009, 107, 309–311. [CrossRef][PubMed]
94. Petrick, J.S.; Jagadish, B.; Mash, E.A.; Aposhian, H.V. Monomethylarsonous acid (MMAIII) and arsenite: Ld(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 2001, 14, 651–656. [CrossRef][PubMed]
95. Hall, M.N.; Gamble, M.V. Nutritional manipulation of one-carbon metabolism: Effects on arsenic methylation and toxicity. J. Toxicol. 2012, 2012, 595307. [CrossRef][PubMed]
96. Karrari, P.; Mehrpour, O.; Abdollahi, M. A systemic review on status of lead pollution and toxicity in Iran; Guidance for preventive measures. DARU J. Pharm. Sci. 2012, 20, 2. [CrossRef][PubMed]
97. Malekirad, A.A.; Oryan, S.; Fani, A.; Babapor, V.; Hashemi, M.; Baeeri, M.; Bayrami, Z.; Abdollahi, M. Study on clinical and biochemical toxicity biomarkers in a zinc-lead mine workers. Toxicol. Ind. Health 2010, 26, 331–337. [CrossRef][PubMed]
98. Hernberg, S. Lead poisoning in a historical perspective. Am. J. Ind. Med. 2000, 38, 244–254. [CrossRef]
99. Jalali, M.; Khanlari, Z.V. Enviromental contamination of Zn, Cd, Ni, Cu and Pb from industrial areas in Hamadan Province, western Iran. Environ. Geol. 2008, 55, 1537–1543. [CrossRef]
100. Parizanganeh, A.; Hajisoltani, P.; Zamani, A. Assessment of heavy metal pollution in surficial soils surrounding Zinc Industrial Complex in Zanjan-Iran. Procedia Environ. Sci. 2010, 2, 162–166. [CrossRef]
101. Ebrahimi, A.; Amin, M.M.; Hashemi, H.; Foladifard, R.; Vahiddastjerdi, M. A survey of groundwater chemical quality in Sajad Zarinshahr. Health Syst. Res. 2011, 6, 918–926.
102. Advisory Committee on Childhood Lead Poisoning Prevention. Recommendations for blood lead screening of young children enrolled in Medicaid: Targeting a group at high risk. MMWR Morb. Mortal. Wkly. Rep. 2000, 49, 1–13.
103. Abdollahi, M.; Ebrahimi-Mehr, M.; Nikfar, S.; Jalali, N. Monitoring of lead poisoning in simple workers of a copying center by flame atomic absorption spectroscopy. MJIRI 1996, 10, 69–72.
104. Nelson, L.; Lewin, N.; Howland, M.A.; Hoffman, R.; Goldfrank, L.; Flomenbaum, N. Goldfrank’s Toxicologic Emergencies, 9th ed.; Mc Graw Hill: New York, NY, USA, 2011; 1266–1280.
105. Pourmand, A.; Al-tiae, T.K.; Mazer-Amirshahi, M. Perspective of lead toxicity, a comparison between the United States and Iran. DARU J. Pharm. Sci. 2012, 20, 70. [CrossRef][PubMed]
106. Rogan, W.J.; Dietrich, K.N.; Ware, J.H.; Dockery, D.W.; Salganik, M.; Radcliffe, J.; Jones, R.L.; Ragan, N.B.; Chisolm, J.J., Jr.; Rhoads, G.G. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N. Eng. J. Med. 2001, 344, 1421–1426. [CrossRef][PubMed]
107. Neal, A.P.; Guilarte, T.R. Mechanism of lead and manganese neurotoxicity. Toxic Res. 2013, 2, 99–114. [CrossRef][PubMed]
108. Papanikolaou, N.C.; Hatzidaki, E.G.; Belivanis, S.; Tzanakakis, G.N.; Tsatsakis, A.M. Lead toxicity update. A brief review. Med. Sci. Monitor 2005, 11, 329.
109. Azizi, M.H.; Azizi, F. Lead Poisoning in the world and Iran. Int. J. Occup. Environ. Med. 2010, 1, 81–87. [PubMed]
110. Centers for Disease Control and Prevention. Preventing Lead Poisoning in Young Children; Centers for Disease Control: Atlanta, GA, USA, 2005.
111. Ziegler, E.E.; Edwards, B.B.; Jensen, R.L.; Mahaffey, K.R.; Fomon, S.J. Absorption and retention of lead by infants. Pediatr. Res. 1978, 12, 29–34. [CrossRef][PubMed]
112. EFSA CONTAM. European food safety authority panel on contaminants in the food chain (CONTAM); scientific opinion on lead in food. EFSA J. 2010, 8, 1570.
113. Gulson, B.L.; Mizon, K.J.; Korsch, M.J.; Palmer, J.M.; Donnelly, J.B. Mobilization of lead from human bone tissue during pregnancy and lactation—A summary of long-term research. Sci. Total Environ. 2003, 303, 79–104. [CrossRef]
114. Skoczynska, A. Genetic aspects of hypertensive effect of lead. Med. Pr. 2008, 59, 325–332. [PubMed]
115. Ahamed, M.; Siddiqui, M.K.J. Low level lead exposure and oxidative stress: Current opinions. Clin. Chem. Acta 2007, 383, 57–64. [CrossRef][PubMed]
116. Blumberg, W.E.; Eisinger, J.; Lamola, A.A.; Zuckerman, D.M. Principles and applications of hematofluorometry. J. Clin. Lab. Autom. 1984, 4, 29–42.
117. Douki, T.; Onuki, J.; Medeiros, M.H.; Bechara, E.J.H.; Cadet, J.; DiMascio, P. DNA alkylation by 4,5-dioxovaleric acid, the final oxidation product of 5-aminolevulinic acid. Chem. Res. Toxicol. 1998, 11, 150–157. [CrossRef][PubMed]
118. Douki, T.; Onuki, J.; Medeiros, M.H.; Bechara, E.J.H.; Cadet, J.; Di Mascio, P. Hydroxy radicals are involved in the oxidation of isolated and cellular DNA bases by 5-aminolevulinic acid. FEBS Lett. 1998, 428, 93–96. [CrossRef]
119. Donaldson, W.E.; Knowles, S.O. Is lead toxicosis a reflection of altered fatty acid composition ofmembrane? Comp. Biochem. Physiol. Part C Comp. Pharm. 1993, 104, 377–379. [CrossRef]
120. Navas-Acien, A.; Guallar, E.; Silbergeld, E.K.; Rothenberg, S.J. Pb exposure and cardiovascular disease—A systematic review. Environ. Health Perspect. 2007, 115, 472–482. [CrossRef][PubMed]
121. Poreba, R.; Gac, P.; Poreba, M.; Andrzejak, R. Environmental and occupational exposure to lead as a potential risk factor for cardiovascular diseases. Environ. Toxicol. Pharm. 2011, 31, 267–277. [CrossRef][PubMed]
122. Poreba, R.; Poreba, M.; Gac, P.; Andrzejak, R. Ambulatory blood pressure monitoring and structural changes in carotid arteries in normotensive workers occupationally exposed to lead. Hum. Exp. Toxicol. 2011, 30, 1174–1180. [CrossRef][PubMed]
123. Poreba, R.; Gac, P.; Poreba, M.; Derkacz, A.; Pilecki, W.; Antonowicz-juchniewicz, J.; Andrzejak, R. Relationship between chronic exposure to lead, cadmium and manganese, blood pressure values and incidence of arterial hypertension. Med. Pr. 2010, 61, 5–14. [PubMed]
124. Khalil-Manesh, F.; Gonick, H.C.; Weiler, E.J.; Prins, B.; Weber, M.A.; Purdy, R. Lead induced hypertension: Possible role of endothelial factors. Am. J. Hypertens. 1993, 6, 723–729. [PubMed]
125. Gonick, H.C.; Ding, Y.; Bondy, S.C.; Ni, Z.; Vaziri, N.D. Lead-induced hypertension I: Interplay of nitric oxide and reactive oxygen species. Hypertension 1997, 30, 1487–1492. [CrossRef][PubMed]
126. Zawadzki, M.; Poreba, R.; Gac, P. Mechanisms and toxic effects of lead on the cardiovascular system. Med. Pr. 2006, 57, 543–549. [PubMed]
127. Vargas, H.; Castillo, C.; Posadas, F.; Escalante, B. Acute lead exposure induces renal heme oxygenase-1 and decreases urinary Na+ excretion. Hum. Exp. Toxicol. 2003, 22, 237–244. [CrossRef][PubMed]
128. Mathew, B.B.; Tiwari, A.; Jatawa, S.K. Free radicals and antioxidants: A review. J. Pharm. Res. 2011, 4, 4340–4343.
129. Flora, G.; Gupta, D.; Tiwari, A. Toxicity of lead: A review with recent updates. Interdiscip. Toxicol. 2012, 5, 47–58. [CrossRef][PubMed]
130. Brochin, R.; Leone, S.; Phillips, D.; Shepard, N.; Zisa, D.; Angerio, A. The cellular effect of lead poisoning and its clinical picture. GUJHS 2008, 5, 1–8.
131. Halliwell, B.; Gutteridge, J.M.C. Free Radicals in Biology and Medicine; Oxford University Press: Oxford, UK, 1999.
132. Babior, B.M. NADPH oxidase: An update. Blood 1999, 93, 1464–1476. [PubMed]
133. Cadenas, E.; Davies, K.J. Mitochondrial free radical generation, oxidative stress and aging. Free Radic. Biol. Med. 2000, 29, 222–230. [CrossRef]
134. Cadenas, E. Biochemistry of oxygen toxicity. Annu. Rev. Biochem. 1989, 58, 79–110. [CrossRef][PubMed]
135. Pastor, N.; Weinstein, H.; Jamison, E.; Brenowitz, M. A detailed interpretation of OH radical footprints in a TBP–DNA complex reveals the role of dynamics in the mechanism of sequence specific binding. J. Mol. Biol. 2000, 304, 55–68. [CrossRef][PubMed]
136. Szabo, C.; Ischiropoulus, H.; Radi, R. Peroxynitrite: Biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Dicov. 2007, 6, 662–680. [CrossRef][PubMed]
137. Winterbourn, C.C.; Hampton, M.B. Thiol chemistry and specificity in redox signalling. Free Radic. Biol. Med. 2008, 45, 549–561. [CrossRef][PubMed]
138. Sharma, S.K.; Goloubinoff, P.; Christen, P. Non-Native Proteins as Newly Identified Targets of Heavy Metals and Metalloids. In Cellular Effects of Heavy Metals; Bánfalvi, G., Ed.; Springer: Heidelberg, Germany, 2011; 263–274.
139. Valko, M.; Morris, H.; Cronin, M.T.D. Metals, toxicity and oxidative stress. Curr. Med. Chem. 2005, 12, 1161–1208. [CrossRef][PubMed]
140. Stadtman, E.R. Role of oxidant species in aging. Curr. Med. Chem. 2004, 11, 1105–1112. [CrossRef][PubMed]
141. Ghezzi, P. Oxidoreduction of protein thiols in redox regulation. Biochem. Soc. Trans. 2005, 33, 1378–1381. [CrossRef][PubMed]
142. Sharma, S.K.; Goloubinoff, P.; Christen, P. Heavy metal ions are potent inhibitors of protein folding. Biochem. Biophys. Res. Commun. 2008, 372, 341–345. [CrossRef][PubMed]
143. Jacobson, T.; Navarrete, C.; Sharma, S.K.; Sideri, T.C.; Ibstedt, S.; Priya, S.; Grant, C.M.; Christen, P.; Goloubinoff, P.; Tamas, M.J. Arsenite interferes with protein folding and triggers formation of protein aggregates in yeast. J. Cell Sci. 2012, 125, 5073–5083. [CrossRef][PubMed]
144. Reyes, J.L.; Molina-Jijon, E.; Rodriguez-Munoz, R.; Bautista-Gracia, P.; Debray-Gracia, Y.; Namorada, M.C. Tight junction proteins and oxidative stress in heavy metals induced nephrotoxicity. BioMed Res. Int. 2013, 2013, 730789.
145. Tamas, M.J.; Sharma, S.K.; Ibstedt, S.; Jacobson, T.; Christen, P. Heavy metals and metalloids as a cause for protein misfolding and aggregation. Biomolecules 2014, 4, 252–267. [CrossRef][PubMed]
146. Niki, E. Lipid peroxidation: Physiological levels and dual biological effects. Free Radic. Biol. Med. 2009, 47, 469–484. [CrossRef][PubMed]
147. Esterbauer, H.; Schaur, J.S.; Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11, 81–128. [CrossRef]
148. Uchida, K. 4-hydroxy-2-nonenal: A product and modulator of oxidative stress. Prog. Lipid Res. 2003, 42, 318–343. [CrossRef]
149. Poli, G.; Biasi, F.; Leonarduzzi, G. 4-hydroxynonenal—protein adducts: A reliable biomarker of lipid oxidation in liver diseases. Mol. Asp. Med. 2008, 29, 67–71. [CrossRef][PubMed]
150. Poli, G.; Schaur, R.J.; Siems, W.G.; Leonarduzzi, G. 4-hydroxynonenal: A membrane lipid oxidation product of medicinal interest. Med. Res. Rev. 2008, 28, 569–631. [CrossRef][PubMed]
151. Lucesoli, F.; Fraga, C.G. Oxidative damage to lipids and DNA concurrent with decrease of antioxidants in rat testes after acute iron intoxication. Arch. Biochem. Biophys. 1995, 316, 567–571. [CrossRef][PubMed]
152. Sole, J.; Huguet, J.; Arola, L.; Romeu, A. In vivo effects of nickel and cadmium in rats on lipid peroxidation and ceruloplasmin activity. Bull. Environ. Contam. Toxicol. 1990, 44, 686–691. [CrossRef][PubMed]
153. Kasprzak, K.S. Possible role of oxidative damage in metalinduced carcinogenesis. Cancer Investig. 1995, 13, 411–430. [CrossRef]
154. Cooke, M.S.; Evans, M.D.; Dizdaroglu, M.; Lunec, J. Oxidative DNA damage: Mechanisms, mutation and disease. FASEB J. 2003, 17, 1195–1214. [CrossRef][PubMed]
155. Jan, A.T.; Azam, M.; Ali, A.; Haq, Q.M.R. Prospects for exploiting bacteria for bioremediation of metal pollution. Crit. Rev. Environ. Sci. Technol. 2014, 44, 1–42. [CrossRef]
156. O’Neill, P.; Chapman, P.W. Potential repair of free radical adducts of dGMP and dG by a series of reductants. A pulse radiolytic study. Int. J. Radiat. Biol. Relat. Study Phys. Chem. Med. 1985, 47, 71–80. [CrossRef]
157. Dizdaroglu, M. Oxidative damage to DNA in mammalian chromatin. Mutat. Res. 1992, 275, 331–342. [CrossRef]
158. Breen, A.P.; Murphy, J.A. Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 1995, 18, 1033–1077. [CrossRef]
159. Burcham, P.C. Internal hazards: Baseline DNA damage by endogenous products of normal metabolism. Mutat. Res. 1999, 443, 11–36. [CrossRef]
160. Laval, F.; Wink, D.A.; Laval, J. A discussion of mechanisms of NO genotoxicity: Implication of inhibition of DNA repair proteins. Rev. Physiol. Biochem. Pharmacol. 1997, 131, 175–191. [PubMed]
161. Jaiswal, M.; LaRusso, N.F.; Nishioka, N.; Nakabeppu, Y.; Gores, G.J. Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide. Cancer Res. 2001, 61, 6388–6393. [PubMed]
162. Haghdoost, S.; Czene, S.; Naslund, I.; Skog, S.; Harms-Ringdahl, M. Extracellular 8-oxo-dG as a sensitive parameter for oxidative stress in vivo and in vitro. Free Radic. Res. 2005, 39, 153–162. [CrossRef][PubMed]
163. Jaruga, P.; Dizdaroglu, M. Repair of products of oxidative DNA base damage in human cells. Nucleic Acids Res. 1996, 24, 1389–1394. [CrossRef][PubMed]
164. DeBont, R.; Larebeke, N. Endogenous DNA damage in humans: A review of quantitative data. Mutagenesis 2004, 19, 169–185. [CrossRef]
165. David, S.S.; O’Shea, V.L.; Kundu, S. Base-excision repair of oxidative DNA damage. Nature 2007, 447, 941–950. [CrossRef][PubMed]
166. Masella, R.; DiBenedetto, R.; Vari, R.; Filesi, C.; Giovannini, C. Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J. Nutr. Biochem. 2005, 16, 577–586. [CrossRef][PubMed]
167. Deleve, L.D.; Kaplowitz, N. Glutathione metabolism and its role in hapatotoxicity. Pharmacol. Ther. 1991, 52, 287–305. [CrossRef]
168. Rabenstein, D.L. Metal complexes of glutathione and their biological significance. In Glutathione: Chemical, Biochemical and Medical Aspects; Dolphin, D., Avramomic, O., Poulson, R., Eds.; John Wiley and Sons: New York, NY, USA, 1998; 147–186.
169. Lund, B.O.; Miller, D.M.; Woods, J.S. Studies on mercury (II) induced H2O2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem. Pharmacol. 1993, 45, 2017–2024. [CrossRef]
170. Valko, M.; Rhodes, C.; Monco, J.; Izakovic, M.; Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160, 1–40. [CrossRef][PubMed]
171. Niki, E. Assesment of antioxidant capacity in vitro and in vivo. Free Radic. Biol. Med. 2010, 49, 503–515. [CrossRef][PubMed]
172. Chapman, L.; Chan, H.M. The influence of nutrition on methylmercury intoxication. Environ. Health Perspect. 2000, 108, 29–56. [CrossRef][PubMed]
173. Pisoschi, A.M.; Pop, A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur. J. Med. Chem. 2015, 97, 55–74. [CrossRef][PubMed]
174. Rooney, J.P.K. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology 2007, 234, 145–156. [CrossRef][PubMed]
175. Peraza, M.A.; Ayala Fierro, F.; Barber, D.S.; Casarez, E.; Rael, L.T. Effects of micronutrients on metal toxicity. Environ. Health Perspect. 1998, 106, 203–216. [CrossRef][PubMed]
176. Hsu, P.C.; Guo, Y.L. Antioxidant nutrients and lead toxicity. Toxicology 2002, 180, 33–44. [CrossRef]
177. Oroian, M.; Escriche, I. Antioxidants: Characterization, natural sources, extraction and analysis. Food Res. Int. 2015, 74, 10–36. [CrossRef]
178. Wojcik, M.; Burzynska-pedziwiatr, I.; Woznaik, L.A. A review of natural and synthetic antioxidants important for health and longevity. Curr. Med. Chem. 2010, 17, 3262–3288. [CrossRef][PubMed]
179. Ahmed, R.G.; Incerpi, S.; Ahmed, F.; Gaber, A. The developmental and physiological interaction between free radicals and antioxidant defense system: Effect of environmental pollutants. J. Natl. Sci. Res. 2013, 3, 74–110.
180. Sato, H.; Tamba, M.; Ishii, T.; Bannai, S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 1999, 274, 11455–11458. [CrossRef][PubMed]
181. Bonanomi, L.; Gazzaniga, A. Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur. J. Res. Dis. 1980, 61, 45–51.
182. DeVries, N.; DeFlora, S. N-acetylcysteine. J. Biol. Chem. 1993, 17, 270–277.
183. DeFlora, S.; Rossi, G.A.; DeFlora, A. Metabolic, dismutagenic and anticarcinogenic effects of N-acetylcysteine. Respiration 1986, 50, 43–49. [CrossRef]
184. Huxtable, R.Physiological action of taurine. Physiol. Rev. 1992, 72, 101–163. [PubMed]
185. Huxtable, R. Expanding the circle 1975–1999: Sulfur biochemistry and insights on the biological functions of taurine. Adv. Exp. Med. Biol. 2000, 483, 1–25. [PubMed]
186. Zelikovic, I.; Chesney, R.W.; Friedman, A.L.; Ahlfors, C.E. Taurine depletion in very low birth weight infants receiving prolonged total parenteral nutrition: role of renal immaturity. J. Pediatr. 1990, 116, 301–306. [CrossRef]
187. Howard, D.; Thompson, D.F. Taurine: An essential amino acid to prevent cholestasis in neonates. Ann. Pharmacother. 1992, 26, 1390–1392. [PubMed]
188. Okamoto, E.; Rassin, D.K.; Zucker, C.L.; Salen, G.S.; Heird, W.C. Role of taurine in feeding the low-birth-weight infant. J. Pediatr. 1984, 104, 936–940. [CrossRef]
189. Vinton, N.E.; Laidlaw, S.A.; Ament, M.E.; Kopple, J.D. Taurine concentrations in plasma, blood cells and urine of children undergoing long-term parenteral nutrition. Pediatr. Res. 1987, 21, 399–405. [CrossRef][PubMed]
190. Wallace, D.R.; Dawson, R. Decreased plasma taurine in aged rats. Gerontology 1990, 36, 19–27. [CrossRef][PubMed]
191. Wu, Q.D.; Wang, J.H.; Fennessy, F.; Redmond, H.P.; Bouchier-Hayes, H.D. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am. J. Physiol. 1999, 277, 1229–1238.
192. Son, M.; Ko, J.I.; Kim, W.B.; Kang, H.K.; Kim, B.K. Taurine can ameliorate inflammatory bowel disease in rats. Adv. Exp. Med. Biol. 1998, 442, 291–298. [PubMed]
193. Kendler, B.S. Recent nutritional approaches to the prevention and therapy of cardiovascular disease. Prog. Cardiovasc. Nurs. 1997, 12, 3–23. [PubMed]
194. Hwang, D.F.; Wang, L.C.; Cheng, H.M. Effect of taurine on toxicity of copper in rats. Food Chem. Toxicol. 1998, 36, 239–244. [CrossRef]
195. Neal, R.; Cooper, K.; Kellogg, G.; Gwer, H.; Ercal, N. Effect of some sulfur containing antioxidants on lead exposed lenses. Free Radic. Biol. Med. 1999, 26, 239–243. [CrossRef]
196. McGowan, C.; Donaldson, W.E. Effect of lead toxicity on the organ concentration of glutathione and glutathione-related free amino acids in the chick. Toxicol. Lett. 1987, 38, 265–270. [CrossRef]
197. Herrero, M.C.; Alvarez, C.; Cartana, J.; Blade, C.; Arola, L. Nickel effects on hepatic amino acids. Res. Commun. Chem. Pathol. Pharmacol. 1993, 79, 243–248. [PubMed]
198. Menendez-Pelaez, A.; Poeggeler, B.; Reiter, R.J.; Barlow-Walden, L.; Pablos, M.I.; Tan, D.X. Nuclear localization of melatonin in different mammalian tissues: Immunocytochemical and radioimmunoassay evidence. J. Cell. Biochem. 1993, 53, 373–382. [CrossRef][PubMed]
199. Okatani, Y.; Okamoto, K.; Hayashi, K.; Wakatsuki, A.; Tamura, S.; Sagara, Y. Maternal-fetal transfer of melatonin in pregnant women near term. J. Pineal Res. 1998, 25, 129–134. [CrossRef][PubMed]
200. Quiroz, Y.; Ferrebuz, A.; Romero, F.; Vaziri, N.D.; Rodriguez-Iturbe, B. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. Am J. Physiol. Ren. Physiol. 2008, 294, 336–344. [CrossRef][PubMed]
201. Kotler, M.; Rodriguez, C.; Sainz, R.M.; Antolin, I.; Menendez-Pelaez, A. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J. Pineal Res. 1998, 24, 83–89. [CrossRef][PubMed]
202. Rodriquez, C.; Mayo, J.C.; Sainz, R.M.; Antolin, I.; Herrera, F.; Martin, V.; Reiter, R.J. Regulation of antioxidant enzymes: A significant role for melatonin. J. Pineal Res. 2004, 36, 1–9. [CrossRef]
203. Pieri, C.; Marra, M.; Moroni, F.; Recchioni, R.; Marcheselli, F. Melatonin—A peroxide radical scavenger more effective than vitamin E. Life Sci. 1994, 55, 271–276. [CrossRef]
204. Tan, D.X.; Chen, L.D.; Poeggler, B.; Manchester, L.C.; Reiter, R.J. Melatonin: A potent endogenous hydroxyl radical scavenger. Endocr. J. 1993, 1, 57–60.
205. Melchiorri, R.J.; Reiter, A.M.; Atlia, M.; Hara, A.; Burgos-Nistico, G. Potent protective effect of melatonin on in vivo paraquat induced oxidative damage in rats. Life Sci. 1995, 56, 83–89. [CrossRef]
206. Othman, A.; Sharawy, S.A.; Missiry, M.A.E. Role of melatonin in ameliorating lead induced haematotoxicity. Pharmacol. Res. 2004, 50, 301–307. [CrossRef][PubMed]
207. Cano, P.; Poliandri, A.H.B.; Jimenez, V.; Cardinali, D.P.; Esquifino, A.I. Cadmium induced changes in Per 1 and Per 2 gene expression in rat hypothalamus and anterior pitutory: Effect of melatonin. Toxicol. Lett. 2007, 172, 131–136. [CrossRef][PubMed]
208. National Academy of Sciences. Dietary Reference Intake: Application in dietary assessment. 2000. Available online: http://www.nap.edu/(accessed on 28 September 2015).
209. Letavayova, L.; Vlckova, V.; Brozmanova, J. Selenium: From cancer prevention to DNA damage. Toxicology 2006, 227, 1–14. [CrossRef][PubMed]
210. Kryukov, G.V.; Castellano, S.; Novoselov, S.V.; Lobanov, A.V.; Zehtab, O.; Guigo, R.; Gladyshev, V.N. Characterization of mammalian selenoproteomes. Science 2003, 300, 1439–1443. [CrossRef][PubMed]
211. Foster, C.B.; Aswath, K.; Chanock, S.J.; McKay, H.F.; Peters, U. Polymorphism analysis of six selenoprotein genes: support for a selective sweep at the glutathione peroxidase 1 locus (3p21) in Asian populations. BMC Genet. 2006, 7, 56. [CrossRef][PubMed]
212. Rayman, M.P. The importance of selenium to human health. Lancet 2000, 356, 233–241. [CrossRef]
213. Trueba, G.P.; Sanchez, G.M.; Giuliani, A. Oxygen free radical and antioxidant defense mechanism in cancer. Front. Biosci. 2004, 9, 2029–2044. [CrossRef][PubMed]
214. Othman, A.; El-Missiry, M.A. Role of selenium against lead toxicity in male rats. J. Biochem. Mol. Toxicol. 1998, 12, 345–349. [CrossRef]
215. Abdulla, M.; Chmielnicka, J. New aspects on the distribution and metabolism of essential trace elements after dietary exposure to toxic metals. Biol. Trace Elem. 1990, 23, 25–53. [CrossRef]
216. Whagner, P.D.Selenium in the treatment of heavy metal poisoning and chemical carcinogenesis. J. Trace Elem. Electro. Health Dis. 1992, 6, 209–221.
217. Suzuki, K.T. Equimolar Hg-Se complex binds to selenoprotein-P. Biochem. Biophy. Res. Commun. 1997, 231, 7–11.
218. Kalia, K.; Flora, S.J.S. Safe and effective therapeutic measures for chronic arsenic and lead poisoning. J. Occup. Health 2005, 47, 1–21. [CrossRef][PubMed]
219. Combs, G.F., Jr.; Midthune, D.N.; Patterson, K.Y.; CanWeld, W.K.; Hill, A.D.; Levander, O.A.; Taylor, P.R.; Moler, J.E.; Patterson, B.H. Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults. Am. J. Clin. Nutr. 2009, 89, 1808–1814. [CrossRef][PubMed]
220. Bronzetti, G.; Cini, M.; Andreoli, E.; Caltavuturo, L.; Panunzio, M.; Croce, C.D. Protective effects of vitamins and selenium compounds in yeast. Mutat. Res. 2001, 496, 105–115. [CrossRef]
221. Fang, Y.; Yang, S.; Wu, G. Free radicals, antioxidants and nutrition. Nutrition 2002, 18, 872–879. [CrossRef]
222. Stoltzfus, R.J. Defining iron-deficiency anemia in public health terms: Time for reflection. J. Nutr. 2001, 131, 565–567.
223. WHO. WHO World Wide Prevalence of Anaemia 1993–2005: WHO Global Database on Anaemia; De Benoist, B., McLean, E., Egli, I., Cogswell, M., Eds.; Centers for Disease Control: Atlanta, GA, USA, 2008.
224. Gutteridge, J. Ferrous ion-EDTA-stimulated phospholipids peroxidation. A reaction changing from alkoxyl-radical to hydroxyl-radical dependent initiation. Biochem. J. 1984, 224, 697–701. [CrossRef][PubMed]
225. Tadolini, B.; Hakim, G. The mechanism of iron (III) stimulation of lipid peroxidation. Free Radic. Res. 1996, 25, 221–227. [CrossRef][PubMed]
226. Oteiza, P.; Mackenzie, G.; Verstraeten, S. Metals in neurodegeneration: involvement of oxidants and oxidant-sensitive transcription factors. Mol. Asp. Med. 2004, 25, 103–115. [CrossRef][PubMed]
227. Labbe, R. Lead poisoning mechanisms. Clin. Chem. 1990, 36, 1870. [PubMed]
228. Briner, W. The alchemists approach to metal poisoning: Transforming the metal burden. Toxics 2014, 2, 364–376. [CrossRef]
229. DeFeo, C.J.; Aller, S.G.; Unger, V.M. A structural perspective on copper uptake in eukaryotes. Biometals 2007, 20, 705–716. [CrossRef][PubMed]
230. Kim, B.E.; Nevitt, T.; Thiele, D.J. Mechanisms for copper acquisition, distribution and regulation. Nat. Chem. Biol. 2008, 4, 176–185. [CrossRef][PubMed]
231. Flora, S.J.S.; Behari, J.R.; Tandon, S.K. Protective role of trace metals in lead intoxication. Toxicol. Lett. 1982, 13, 51–56. [CrossRef]
232. Millier, G.D.; Massaro, T.F.; Massaro, E.J. Interaction between lead and essential elements—A review. Neurotoxicology 1990, 11, 99–120.
233. Halliwell, B.; Gutteridge, J.M. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol. 1990, 186, 1–85. [PubMed]
234. Rae, T.D.; Schmidt, P.J.; Pufahl, R.A.; Culotta, V.C.; O’Halloran, T.V. Undetectable intracellular free copper: The requirement of a copper chaperone for superoxide dismutase. Science 1999, 284, 805–808. [CrossRef][PubMed]
235. O’Halloran, T.V.; Culotta, V.C. Metallochaperones: an intracellular shuttle service for metal ions. J. Biol. Chem. 2000, 275, 25057–25060. [CrossRef][PubMed]
236. Mocchegiani, E.; Muzzioli, M. Zinc, metallothioneins, immune response, survival and ageing. Biogerontology 2000, 1, 133–143. [CrossRef][PubMed]
237. Mocchegiani, E.; Muzzioli, M.; Giacconi, R. Zinc and immunoresistance to infections in ageing: New biological tools. Trends Pharmacol. Sci. 2000, 21, 205–208. [CrossRef]
238. Vasak, M.; Hasler, D.W. Metallothioneins: New functional and structural insights. Curr. Opin. Chem. Biol. 2000, 4, 177–183. [CrossRef]
239. Coyle, P.; Philcox, J.C.; Carey, L.C.; Rofe, A.M. Metallothionein: The multipurpose protein. Cell. Mol. Life Sci. 2002, 59, 627–647. [CrossRef][PubMed]
240. Jamieson, J.A.; Taylor, C.G.; Weiler, H.A.Marginal zinc deficiency exacerbates bone lead accumulation and high dietary zinc attenuates lead accumulation at the expense of bone density in growing rats. Toxicol. Sci. 2006, 92, 286–294. [CrossRef][PubMed]
241. Flora, S.J.S.; Singh, S.; Tandon, S.K. Thiamine and zinc in prevention of lead intoxication. J. Int. Med. Res. 1989, 17, 68–75. [PubMed]
242. Flora, S.J.S.; Kumar, D.; Gupta, D. Intereaction of zinc, methionine or their combination with lead at gastrointestinal or post-absorptive levels in rats. Pharmacol. Toxicol. 1999, 68, 3–7. [CrossRef]
243. Franciscato, C.; Silva, L.M.; Duarte, F.A.; Oliveira, C.S.; Ineu, R.P.; Flores, E.M.M.; Dressler, V.L.; Piexoto, N.C.; Pereira, M.E. Delayed biochemical changes induced by mercury intoxication are prevented by zinc exposure. Ecotoxicol. Environ. Saf. 2011, 74, 480–486. [CrossRef][PubMed]
244. Guzzi, G.; LaPorta, C.A.M. Molecular mechanisms triggered by mercury. Toxicology 2008, 244, 1–12. [CrossRef][PubMed]
245. Maret, W.; Sandstead, H.H. Zinc requirements and the risks and benefits of zinc supplementation. J. Trace Elem. Med. Biol. 2006, 20, 3–18. [CrossRef][PubMed]
246. Menvielle-Bourg, F.J. Superoxide Dismutase (SOD), a Powerful Antioxidant, is now available orally. Phytotherapie 2005, 3, 1–4.
247. Landis, G.N.; Tower, J. Superoxide dismutase evolution and life span regulation. Mech. Ageing Dev. 2005, 126, 365–379. [CrossRef][PubMed]
248. Mates, J.M.; Perez-Gomez, C.; DeCastro, I.N. Antioxidant enzymes and human diseases. Clin. Biochem. 1999, 32, 595–603. [CrossRef]
249. Behrend, L.; Henderson, G.; Zwacka, R.M. Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans. 2003, 31, 1441–1444. [CrossRef][PubMed]
250. Lodge, J.; Packer, L. Natural source of lipoic acid in plant and animal tissues. In Antioxidant Food Supplements in Human Health; Packer, L., Hiramatsu, M., Yoshikawa, T., Eds.; Academic Press: San Diego, CA, USA, 1999; p. 121.
251. Wollin, S.D.; Jones, P.L. a-lipoic acid and cardiovascular disease. J. Nutr. 2003, 133, 3327–3330. [PubMed]
252. Marquet, A.; TseSum, B.B.; Florentin, D. Biosynthesis of biotin and lipoic acid. Vitam. Horm. 2001, 61, 51–94. [PubMed]
253. Ou, P.; Tritscher, H.J.; Wolff, S.P. Thioctic (Lipoic) acid: A therapeutic metal chelating antioxidant. Biochem. Pharmacol. 1995, 50, 123–126. [CrossRef]
254. Bustamante, J.; Lodge, J.K.; Marcocci, L.; Tritschler, H.J.; Packer, L.; Rihn, B.H. a-lipoic acid in liver metabolism and disease. Free Radic. Biol. Med. 1998, 24, 1023–1039. [CrossRef]
255. Arivazhagan, P.; Ramanathan, K.; Panneerselvam, C. Effect of D,L-a-lipoic acid on mitochondrial enzymes in aged rats. Chem. Biol. Interact. 2001, 138, 189–198. [CrossRef]
256. Reed, L.J. Multienzyme complex. Acc. Chem. Res. 1974, 7, 40–46. [CrossRef]
257. Packer, L.; Kraemer, K.; Rimbach, G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001, 17, 888–895. [CrossRef]
258. Packer, L.; Witt, E.H.; Tritschler, H.J. a-lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 1995, 19, 227–250. [CrossRef]
259. Biewenga, G.P.; Haenen, G.R.M.M.; Bast, A. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 1997, 29, 315–331. [CrossRef]
260. Cremer, D.R.; Rabeler, R.; Roberts, A.; Lynch, B. Long-term safety of a-lipoic acid (ALA) consumption: A 2-year study. Long Regul. Toxicol. Pharmacol. 2006, 46, 193–201. [CrossRef][PubMed]
261. Tiechert, J.; Kern, J.; Tritschler, H.J.; Ulrich, H.; Preib, R. Investigations on the pharmacokinetics of a-lipoic acid in healthy volunteers. Int. J. Clin. Pharm. Ther. 1998, 36, 625–628.
262. Ali, Y.F.; Desouky, O.S.; Selim, N.S.; Ereiba, M. Assessment of the role of a-lipoic acid against the oxidative stress of induced iron overload. J. Radiat. Res. Appl. Sci. 2015, 8, 26–35. [CrossRef]
263. Podda, M.; Tritschler, H.J.; Ulrich, H.; Packer, L. a-lipoic acid supplementation prevents symptoms of vitamin E deficiency. Biochem. Biophys. Res. Commun. 1994, 204, 98–104. [CrossRef][PubMed]
264. Han, D.; Tritscher, H.J.; Packer, L. a-lipoic acid increases intracellular glutathione in a human T-lymphocyte jurkat cell line. Biochem. Biophys. Res. Commun. 1995, 207, 258–264. [CrossRef][PubMed]
265. Vera, J.C.; Rivas, C.I.; Fischbarg, J.; Golde, D.W. Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature 1993, 364, 79–82. [CrossRef][PubMed]
266. Tsukaguchi, H.; Tokui, T.; Mackenzie, B.; Berger, U.V.; Chen, X.Z.; Wang, Y.; Brubaker, R.F.; Hediger, M.A. A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature 1999, 399, 70–75. [PubMed]
267. Expert Group on Vitamins and Minerals (EVM). Safe Upper Levels for Vitamins and Minerals; Food Standard Agency: London, UK, 2003.
268. European Food Safety Authority (EFSA). Opinion of the scientific panel on dietetic products, nutrition and allergies (NDA) on the upper tolerable intake of Vitamin C (L-ascorbic acid, its calcium, potassium and sodium salts and L-ascorbyl-6-palmitate). EFSA J. 2004, 59, 1–21.
269. Pokorski, M.; Marczak, M.; Dymecka, A.; Suchocki, P. Ascorbyl palmitate as a carrier of ascorbate into neural tissues. J. Biomed. Sci. 2003, 10, 193198. [CrossRef]
270. Cuzzorcrea, S.; Thiemermann, C.; Salvemini, D. Potential therapeutic effect of antioxidant therapy in shock and inflammation. Curr. Med. Chem. 2004, 11, 1147–1162. [CrossRef]
271. Kasparova, S.; Brezova, V.; Valko, M.; Horecky, J.; Mlynarik, V.; Liptaj, T.; Vancova, O.; Ulicna, O.; Dobrota, D. Study of the oxidative stress in a rat model of chronic brain hypoperfusion. Neurochem. Int. 2005, 46, 601–611. [CrossRef][PubMed]
272. Meister, A. New aspects of glutathione biochemistry and transport-selective alteration of glutathione metabolism. Nutr. Rev. 1984, 42, 397–410. [CrossRef][PubMed]
273. Meister, A. Glutathione-ascorbic acid antioxidant system in animals. J. Biol. Chem. 1994, 269, 9397–9400. [PubMed]
274. Winkler, B.S.; Orselli, S.M.; Rex, T.S. The redox couple between glutathione and ascorbic acid: A chemical and physiological perspective. Free Radic. Biol. Med. 1994, 17, 333–349. [CrossRef]
275. Henson, D.E.; Block, G.; Levine, M. Ascorbic acid: Biological functions and relation to cancer. J. Natl. Cancer Inst. 1991, 83, 547–550. [CrossRef][PubMed]
276. Halliwell, B. Free radicals and antioxidants: A personal view. Nutr. Rev. 1994, 52, 253–265. [CrossRef][PubMed]
277. Jones, D.P.; Kagan, V.E.; Aust, S.D.; Reed, D.J.; Omaye, S.T. Impact of nutrients on cellular lipid peroxidation and antioxidant defense system. Toxicol. Sci. 1995, 26, 1–7. [CrossRef]
278. Houston, D.K.N.; Johnson, M.A. Does vitamin C intake protects against lead toxicity? Nutr. Rev. 2000, 58, 73–79. [CrossRef][PubMed]
279. Knekt, P.; Jarvinen, R.; Seppanen, R.; Rissanen, A.; Aromaa, A.; Heinonen, O.P.; Albanes, D.; Heinonen, M.; Pukkala, E.; Teppo, L. Dietary antioxidants and the risk of lung-cancer. Am. J. Epidemiol. 1991, 134, 471–479. [PubMed]
280. Carr, A.; Frei, B. Does Vitamin C act as a pro-oxidant under physiological conditions? FASEB J. 1999, 13, 1007–1024. [PubMed]
281. Kojo, S. Vitamin C: Basic metabolism and its function as an index of oxidative stress. Curr. Med. Chem. 2000, 11, 1041–1064. [CrossRef]
282. Ramanathan, K.; Anusuyadevi, M.; Shila, S.; Panneerselvam, C. Ascorbic acid and tocopherol as potent modulators of apoptosis on arsenic induced toxicity in rats. Toxicol. Lett. 2005, 156, 297–306. [CrossRef][PubMed]
283. Flora, S.J.S.; Tandon, S.K. Prevention and therapeutic effects of thiamine, ascorbic acid and their combination in lead intoxication. Acta. Pharmacol. Toxicol. 1986, 58, 374–378. [CrossRef]
284. Dhawan, M.; Kachru, D.N.; Tandon, S.K. Influence of thiamine and ascorbic acid supplementation on antidotal afficacy of thiol chelators in lead intoxication. Arch. Toxicol. 1988, 62, 301–304. [CrossRef][PubMed]
285. Sandmann, G. Carotenoid biosynthesis in microorganisms and plants. Eur. J. Biochem. 1994, 223, 7–24. [CrossRef][PubMed]
286. McNulty, H.P.; Jacob, R.F.; Mason, R.P. Biologic activity of carotenoids related to distinct membrane physicochemical interactions. Am. J. Cardiol. 2008, 101, 20–29. [CrossRef][PubMed]
287. Jackson, H.; Braun, C.L.; Ernst, H. The chemistry of novel xanthophyll carotenoids. Am. J. Cardiol. 2008, 101, 50–57. [CrossRef][PubMed]
288. Schweigert, F. Metabolism of Carotenoids in Mammals; Birkhauser Verlag: Basel, Switzerland, 1998.
289. Guerin, M.; Huntley, M.E.; Olaizola, M. Haematococcus astaxanthin: Applicationsfor human health and nutrition. Trends Biotechnol. 2003, 21, 210–216. [CrossRef]
290. Ambati, R.R.; Phang, S.M.; Ravi, S.; Aswathanarayana, R.G. Astaxanthin: Sources, extraction, stability, biological activities and its commercial applications: A review. Mar. Drugs 2014, 12, 128–152. [CrossRef][PubMed]
291. Fassett, R.G.; Coombes, J.S. Astaxanthin: A potential therapeutic agent in cardiovascular disease. Mar. Drugs 2011, 9, 447–465. [CrossRef][PubMed]
292. Naquib, Y.M. Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 2000, 48, 1150–1154. [CrossRef]
293. Olson, J.A. Carotenoids: Absorption, transport and metabolism in humans. Pure Appl. Chem. 2004, 66, 1011–1016. [CrossRef]
294. Miki, W. Biological function and activities of animal carotenoids. Pure Appl. Chem. 1991, 63, 141–146. [CrossRef]
295. Ranga Rao, A.; Raghunath Reddy, R.L.; Baskaran, V.; Sarada, R.; Ravishankar, G.A. Characterization of microalgal carotenoids by mass spectrometry and their bioavailability and antioxidant properties elucidated in rat models. J. Agric. Food Chem. 2010, 58, 8553–8559. [CrossRef][PubMed]
296. Sharoni, Y.; Danilenko, M.; Dubi, N.; Ben-Dor, A.; Levy, J. Carotenoids and transcription. Arch. Biochem. Biophys. 2004, 430, 89–96. [CrossRef][PubMed]
297. Mortensen, A.; Skibsted, L.H.; Truscott, T.G. The interaction of dietary carotenoids with radical species. Arch. Biochem. Biophys. 2001, 385, 13–19. [CrossRef][PubMed]
298. El-Agamey, A.; Lowe, G.M.; McGarvey, D.J.; Mortensen, A.; Phillip, D.M.; Truscott, T.G. Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch. Biochem. Biophys. 2004, 430, 37–48. [CrossRef][PubMed]